NCT02856256

Brief Summary

The choroid is a richly vascularized conjunctive tissue, providing the nutritive elements to the pigmentary epithelium and the photoreceptors of the retina. It drains 80% of the eye's blood. The choroidal thickness fluctuates according to the state of fullness of its constitutive vessels. The choroid and the neuroretina (separate by the pigmentary epithelium) are intimately linked and are subject to modifications during the ingestion of caffeine and taurine combined. Several authors have shown a significant decrease of the choroidal thickness lasting at least 4 hours after the ingestion of a small coffee. This decrease may be caused by caffeine's vasoconstrictor effect. Taurine is the most abundant amino acid in the retina. Recent studies have shown the importance of this amino acid in the physiology of both, retinal pigmentary epithelium and retinal ganglion cells. RedBull® is an energizing drink, where one single 25 cl can contains 80 mg of caffeine (the equivalent of a coffee mug) and 1 g of taurine. This pilot trial aims to study the variations of the choroidal thickness and to describe possible modifications within the pigmentary epithelium, due to the ingestion of caffeine and taurine. The results of this study will act as a reference for an ulterior trial aiming specific choroidal pathologies of young patients, such as the central serous chorioretinitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 12, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 4, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2017

Completed
Last Updated

May 31, 2017

Status Verified

May 1, 2017

Enrollment Period

1.5 years

First QC Date

August 2, 2016

Last Update Submit

May 29, 2017

Conditions

Keywords

Energy drinkChoroid

Outcome Measures

Primary Outcomes (1)

  • Intra-patient variation of the choroidal thickness

    Measure of choroidal thickness by Optical Coherence Tomography (OCT), 5 minutes before ingesting 25cl RedBull® then 5 minutes, 30 minutes, 1 hour, 2 hours and 4 hours after ingestion of RedBull®.

    up to 4 hours

Study Arms (1)

RedBull® energy drink

EXPERIMENTAL
Dietary Supplement: RedBull® energy drink

Interventions

RedBull® energy drinkDIETARY_SUPPLEMENT

Subjects consume 25 mL of RedBull® energy drink

RedBull® energy drink

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18-45 years old
  • subject under no medical treatment who can alter choroidal depth (sildenafil, diuretics, steroids, etc)
  • Non smoker
  • subject well informed of the trial and having signed consent

You may not qualify if:

  • subject with retinal and/or choroidal abnormalities
  • Diabetic subject
  • Hypermetropia \> +3 diopters and myopia \< -3 diopters
  • History of intra-ocular surgery or laser
  • subject with a history of retinal pathologies
  • Subject not affiliated to French social security
  • Subject under juridical protection
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique Adolphe de Rothschild

Paris, 75019, France

Location

Related Publications (1)

  • Arej N, Azar G, Salviat F, Alonso AS, Zuber K, Metten MA, Salomon L, Vasseur V, Mauget-Faysse M. Study of choroidal thickness variations after ingestion of a taurine and caffeine-containing energy drink. Clin Nutr ESPEN. 2021 Jun;43:245-249. doi: 10.1016/j.clnesp.2021.04.007. Epub 2021 Apr 17.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 4, 2016

Study Start

November 12, 2015

Primary Completion

May 29, 2017

Study Completion

May 29, 2017

Last Updated

May 31, 2017

Record last verified: 2017-05

Locations